178 Influence of the angiotensin-converting enzyme genotype on the response to beta-blocker therapy and the prognosis of the patients with chronic heart failure

Metra, M.; Nodari, S.; Pezzali, N.; Moiza Culot, L.; Fracassi, F.; Covolo, L.; Gelatti, U.; Donato, F.; Nardi, G.; Dei Cas, L.
June 2004
European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p34
Academic Journal
An abstract of the article "Influence of the Angiotensin-Converting Enzyme Genotype on the Response to Beta-Blocker Therapy and the Prognosis of the Patients With Chronic Heart Failure," by M. Metra and colleagues is presented.


Related Articles

  • ACE inhibitors and beta-blockers.  // Patient Care;12/15/1997, Vol. 31 Issue 20, p92 

    Examines the effects of angiotensin-converting enzyme (ACE) inhibitors and beta blockers on the long-term outcome of several cardiovascular disorders. Increase in the number of prescriptions being made for beta blockers for cases of hyperthension; Findings of studies published on the drugs;...

  • In patients with diabetes and hypertension, should treatment start with an ACE inhibitor instead of a diuretic or beta blocker? Mackrides, Paula S.; Shaughnessy, Allen F. // Journal of Family Practice;Mar2002, Vol. 51 Issue 3, p203 

    The article discusses research being done on the treatment of diabetics with hypertension using angiotensin converting enzyme inhibitor instead of a diuretic or beta blocker. It references a study by D. Niskanes et al published in a 2001 issue of "Diabetes Care." This randomized controlled trial...

  • Clinical Clips. Kirchner, Jeffrey; Pohl, Charles A.; Russell, John J. // Patient Care for the Nurse Practitioner;Nov2003, Vol. 6 Issue 11, p3 

    The article presents various clinical clips. The mortality benefits of drug therapy with angiotensin converting enzyme inhibitors, beta-blockers, and spironolactone for congestive heart failure (CHF) have been well established by multiple clinical trials. It was proposed that yet another class...

  • Pharmacoeconomics of beta-blockers: effective and cost-effective therapy in chronic heart failure. Krum, Henry; Lim, Stephen // European Journal of Heart Failure;Aug2001, Vol. 3 Issue 4, p399 

    The authors reflect on the economical value of the use of beta-blockers as treatment for chronic heart failure (CHF). The authors mention that CHF has became a primary economic burden of health care system in many countries like the Netherlands and France. They add that beta-adrenergic blocking...

  • Accelerated whole-heart 3D CSPAMM reveals impact of beta-blocker therapy on myocardial architecture.  // Journal of Cardiovascular Magnetic Resonance (BioMed Central);2010 Supplement 1, Vol. 12, p1 

    An abstract of the article "Accelerated whole-heart 3D CSPAMM reveals impact of beta-blocker therapy on myocardial architecture," by Boris Schmitt is presented.

  • 624 Resource utilisation of specialist nurse-led beta blocker titration: are there any differences between carvedilol and bisoprolol. Travers, B.; Ryder, M.; Ledwidge, M.T.; Oloughlin, C.; Ryan, E.; McDonald, K.M. // European Journal of Heart Failure. Supplements;Jun2004, Vol. 2 Issue 1, p135 

    An abstract of the study "Resource Utilisation of Specialist Nurse-led Beta Blocker Titration: Are There Any Differences Between Carvedilol and Bisoprolol," by B. Travers and colleagues is presented.

  • A step-by-step guide to the heart failure care. Saunders, Carlos S.; Feldman, Arthur M. // Patient Care;6/15/2000, Vol. 34 Issue 11, p154 

    Presents a step by step guide for providing medical care during heart failure (HF). Use of two-dimensional echocardiography and Doppler flow imaging for diagnosis; Complex drug regimen needed for HF; Use of beta-blockers, spironolactone and higher dosages of angiotensin-converting enzyme. ...

  • Beta-blockers and ACE inhibitors: New data, old myths. Pinkowish, Mary Desmond; Francis, Gary S. // Patient Care;7/15/2000, Vol. 34 Issue 13, p62 

    Presents an update on the cardiovascular applications of angiotensin converting enzyme inhibitors and beta-blockers. Appropriate dosages; Adverse reactions; Beta-blockers after surgery; Misunderstandings about the use of beta-blockers in patients with respiratory disease. INSETS: Selected...

  • Strategies to prevent readmissions for heart failure. D'Epiro, Peter; Harjai, Kishore J. // Patient Care;10/15/2000, Vol. 34 Issue 19, p87 

    Examines various measures for reducing hospital readmission rates in patients with heart failure. Use of angiotensin converting enzyme (ACE) inhibitors; Use of angiotensin-receptor blockers or the combination of hydralizine and isosorbide dinitrate; Use of beta-blockers; Use of digoxin and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics